PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW128387View Pathway |
drug action
Sulfisoxazole Action PathwayEscherichia coli (strain K12)
Sulfisoxazole is a short-acting antibiotic from the sulfonamide drug class. It has activity against a wide range of gram-negative and gram-positive organisms. This drug is indicated in the treatment of many infections: urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, nocardiosis, chancroid, toxoplasmosis, malaria, and many others. This drug is bacteriostatic; it inhibits the replication of bacteria by inhibiting the dihydropteroate synthase. This enzyme is responsible for one of the reactions to synthesize folic acid in bacteria by the condensation of the pteridine with para-aminobenzoic acid (PABA). This drug stops the replication of the bacteria (bacteriostatic). Sulfisoxazole is administered as an oral tablet.
|
Creator: Daphnee Created On: August 25, 2023 at 12:43 Last Updated: August 25, 2023 at 12:43 |
PW144392View Pathway |
drug action
Sulfisoxazole Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:33 Last Updated: October 07, 2023 at 13:33 |
PW122077View Pathway |
disease
Sulfite Oxidase DeficiencyRattus norvegicus
Sulfite oxidase deficiency (SOD) is a disorder, an autosomal recessive disease. In classic SOD, it is usually identified a few days after the birth of an affected individual, and is recognizable through characteristic dysmorphic features, seizures, and other signs of progressive encephalopathy. Patients also have ocular lenses that are dislocated, and usually die within a few months of being born. In late- onset SOD, the disorder is identified only in the later months, usually 6-18 months, of the child’s life by a delay or regression of neurological progress. This disorder is very rare, but the actual prevalence is not known. It can be diagnosed through a sulfite test strip in urine or by a skin fibroblast culture, which will indicate an absence of sulfite oxidase.
|
Creator: Ana Marcu Created On: September 10, 2018 at 15:52 Last Updated: September 10, 2018 at 15:52 |
PW121853View Pathway |
disease
Sulfite Oxidase DeficiencyMus musculus
Sulfite oxidase deficiency (SOD) is a disorder, an autosomal recessive disease. In classic SOD, it is usually identified a few days after the birth of an affected individual, and is recognizable through characteristic dysmorphic features, seizures, and other signs of progressive encephalopathy. Patients also have ocular lenses that are dislocated, and usually die within a few months of being born. In late- onset SOD, the disorder is identified only in the later months, usually 6-18 months, of the child’s life by a delay or regression of neurological progress. This disorder is very rare, but the actual prevalence is not known. It can be diagnosed through a sulfite test strip in urine or by a skin fibroblast culture, which will indicate an absence of sulfite oxidase.
|
Creator: Ana Marcu Created On: September 10, 2018 at 15:50 Last Updated: September 10, 2018 at 15:50 |
PW127276View Pathway |
disease
Sulfite Oxidase DeficiencyHomo sapiens
Sulfite oxidase deficiency (SOD) is a disorder, an autosomal recessive disease. In classic SOD, it is usually identified a few days after the birth of an affected individual, and is recognizable through characteristic dysmorphic features, seizures, and other signs of progressive encephalopathy. Patients also have ocular lenses that are dislocated, and usually die within a few months of being born. In late- onset SOD, the disorder is identified only in the later months, usually 6-18 months, of the child’s life by a delay or regression of neurological progress. This disorder is very rare, but the actual prevalence is not known. It can be diagnosed through a sulfite test strip in urine or by a skin fibroblast culture, which will indicate an absence of sulfite oxidase.
|
Creator: Ray Kruger Created On: November 28, 2022 at 11:50 Last Updated: November 28, 2022 at 11:50 |
PW000508View Pathway |
disease
Sulfite Oxidase DeficiencyHomo sapiens
Sulfite oxidase deficiency (SOD) is a disorder, an autosomal recessive disease. In classic SOD, it is usually identified a few days after the birth of an affected individual, and is recognizable through characteristic dysmorphic features, seizures, and other signs of progressive encephalopathy. Patients also have ocular lenses that are dislocated, and usually die within a few months of being born. In late- onset SOD, the disorder is identified only in the later months, usually 6-18 months, of the child’s life by a delay or regression of neurological progress. This disorder is very rare, but the actual prevalence is not known. It can be diagnosed through a sulfite test strip in urine or by a skin fibroblast culture, which will indicate an absence of sulfite oxidase.
|
Creator: WishartLab Created On: August 29, 2013 at 10:39 Last Updated: August 29, 2013 at 10:39 |
PW128466View Pathway |
drug action
Sulfoxone Action PathwayMycobacterium leprae
Sulfoxone, also known as aldesulfone sodium, is a sulfonamide antibiotic with bacteriostatic activity. It is indicated in the treatment of leprosy and dermatitis herpetiformis. Leprosy is caused by Mycobacterium leprae. Sulfoxone inhibits the growth of the bacteria by inhibiting competitively the dihydropteroate synthase enzyme. This results in the inability to bind the substrate, para-aminobenzoic acid (PABA) resulting in the inability of the bacteria to do the synthesis of folic acid. Without folic acid, the bacteria can not grow because it can not produce DNA anymore. Right now this drug has been discontinued. It is administered as an oral tablet.
|
Creator: Daphnee Created On: August 30, 2023 at 09:34 Last Updated: August 30, 2023 at 09:34 |
PW145233View Pathway |
drug action
Sulfoxone Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:22 Last Updated: October 07, 2023 at 15:22 |
PW176425View Pathway |
Sulfoxone Predicted Metabolism PathwayHomo sapiens
Metabolites of Sulfoxone are predicted with biotransformer.
|
Creator: Omolola Created On: December 08, 2023 at 13:51 Last Updated: December 08, 2023 at 13:51 |
PW146234View Pathway |
drug action
Sulfur hexafluoride Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:44 Last Updated: October 07, 2023 at 17:44 |